Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 19-1131
Print  Notify Me  
Search documents in this case:
No. 19-1131
 
Title: Actavis Laboratories FL, Inc., Petitioner
v.
Nalpropion Pharmaceuticals LLC
Docketed: March 16, 2020
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2018-1221)
   Decision Date: August 15, 2019
   Rehearing Denied: December 16, 2019
 
Proceedings and Orders
Mar 13 2020 Petition for a writ of certiorari filed. (Response due April 15, 2020)
Petition Appendix Certificate of Word Count Proof of Service
Apr 15 2020 Brief amicus curiae of Association for Accessible Medicines filed.
Main Document Certificate of Word Count Proof of Service
Apr 15 2020 Brief of respondent Nalpropion Pharmaceuticals LLC in opposition filed.
Main Document Certificate of Word Count Proof of Service
May 04 2020 Reply of petitioner Actavis Laboratories FL, Inc. filed. (Distributed)
Main Document Certificate of Word Count Proof of Service
May 05 2020 DISTRIBUTED for Conference of 5/21/2020.
May 26 2020 Petition DENIED.
Attorneys
Attorneys for Petitioners
William McGinley Jay
Counsel of Record
Goodwin Procter, LLP
1900 N Street, N.W.
Washington, DC 20036

WJay@goodwinlaw.com
Ph: 2023464190
Party name: Actavis Laboratories FL, Inc.


Attorneys for Respondents
Dominick A. Conde
Counsel of Record
Venable LLP
1290 Avenue of the Americas
New York, NY 10104-3800

dconde@venable.com
Ph: 212-218-2100
Party name: Nalpropion Pharmaceuticals LLC


Other Attorneys
Matthew S. Hellman
Counsel of Record
Jenner & Block LLP
1099 New York Ave., NW
Suite 900
Washington, DC 20001

mhellman@jenner.com
Ph: 202-639-6000
Party name: Association for Accessible Medicines


 

SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543